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Treatment of human lymphoblastoid (Daudi) cells with interferons inhibits cell proliferation in culture 
within 24 h. The failure of cell growth has been shown to be associated with impaired processing and 
decreased stability of newly replicated DNA. Because there is a close relationship between DNA replication 
and protein synthesis we have measured protein synthesis in intact Daudi cells. Protein synthesis declined 
steadily between 24 and 96 h after interferon treatment to a value which is only 20-30% of the rate in 
control cells. The enzyme 2’S’-oligo(A) synthetase is induced but our data do not support a role for the 
2’,5’-oligo(A)-activated ribonuclease in the control of translation in this system. 
Interferon Protein synthesis 
DNA replication 
1. INTRODUCTION 
Among the mammalian cell lines which are sen- 
sitive to the cell growth inhibitory effects of inter- 
ferons, the Daudi line of human lymphoblastoid 
cells is one of the most amenable to study [l-7]. 
We are conducting a detailed analysis of the bio- 
chemical mechanisms which underlie the inhibition 
of cell growth and division by human a-interferons 
in this system and have shown that impairment of 
cell proliferation is accompanied by changes in 
DNA replication within 24 h of treatment. Promi- 
nent amongst hese changes are a strong inhibition 
of thymidine kinase activity [2,3], a delay in the 
time required for processing of newly replicated 
Okazaki fragments to larger intermediates of DNA 
replication [5], and instability of a proportion of 
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the newly replicated DNA sequences leading to 
their turnover within a few hours of their synthesis 
[5]. We have proposed that these molecular changes 
may be responsible for the inhibition of cell pro- 
liferation in response to interferon treatment in 
this system. 
The process of DNA replication in mammalian 
cells is tightly coupled with that of protein synthe- 
sis and requirements for newly synthesised protein 
for several steps in the assembly of newly repli- 
cated DNA have been reported [S-lo]. There is 
little information, however, concerning changes in 
the rate or pattern of protein synthesis during the 
response of Daudi cells to interferon treatment. 
We have therefore investigated the changes in pro- 
tein synthesis which accompany growth inhibition 
to determine whether these may be related to the 
inhibition of DNA replication or the decrease in 
stability of newly synthesised DNA. Several mole- 
cular mechanisms for inhibition of protein syn- 
thesis in virus infected, interferon-treated cells 
have been established. These include induction of 
2’,5’-oligo(A) synthetase and the activation of this 
enzyme by double-stranded RNA in virus-infected 
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cells [ 11,121, the induction of a protein kinase 
which can phosphorylate the small subunit of 
initiation factor eIF-2 [ 13,141, and changes in the 
ability of cells to methylate newly synthesised 
mRNA [ 151. The majority of these changes occur 
within the first few hours of interferon treatment 
but may only take effect in the presence of viral 
replicative intermediates. In many studies on the 
effects of interferon on uninfected cells and their 
extracts little change in the rate of overall protein 
synthesis has been observed [16- 191 although there 
are exceptions to this finding [20,21]. In this study 
we have investigated the responses of Daudi cells 
to prolonged interferon treatment (up to 4 days) 
and have established some characteristics of the in- 
hibition of translation observed. 
2. MATERIALS AND METHODS 
2. I. Materials 
Human lymphoblastoid cell interferon prepara- 
tions were kindly provided by Drs K.H. Fantes and 
M.D. Johnston (Wellcome Research Laboratories, 
Beckenham, England). They were diluted in RPM1 
1640 medium in the presence of serum, to minimise 
losses due to adsorption of protein. Radiochemi- 
cals were from Amersham International or New 
England Nuclear. 5,6-Dichloro-l-fl-D-ribofurano- 
sylbenzimadazole (DRB) was from Calbiochem 
and poly(1). poly(C) agarose was from P-L Bio- 
chemicals. 
2.2. Ceil culture and determination of protein 
synthesis 
Daudi cells were grown in culture and treated 
with interferons as in 12-51. Protein synthesis in 
the intact cells was monitored either by use of a 
procedure involving labelling with a high con- 
centration of [3H]phenylalanine [22] or, less 
rigorously, by the incorporation of [ “C]leucine or 
[35S]methionine. In the case of phenylalanine in- 
corporation the specific radioactivity of the pre- 
cursor in the culture medium and in the intracellular 
amino acid pool was determined as in [22]. The 
specific radioactivity of phenylalanine in protein 
was determined on acid hydrolysates by a similar 
method. Full details and characterization of this 
method for use with cultured cells will be described 
elsewhere (M.A. McNurlan et al., in preparation). 
Incorporation of methionine into cell protein was 
112 
determined by trichloroacetic acid precipitation of 
aliquots of cell suspension as in [2-51. 
2.3. Preparation of cell extracts 
Cell extracts were prepared by detergent lysis of 
washed Daudi cells using a modification of a pro- 
cedure previously described for other types of cul- 
tured cells [23]. Lysis was effected with 0.25% 
Nonidet P40 and postmitochondrial supernatants 
were prepared by centrifugation of the lysates at 
10000 x g for 10min. Supernatants were stored in 
small aliquots under liquid nitrogen. 
2.4. Determination of polysome profiles 
The distribution of ribosomes between subunits, 
monomers and polysomes was determined by 
sucrose density gradient centrifugation and frac- 
tionation as in [24]. 
2.5. Protein synthesis in cell extracts 
Incorporation of [ 35S] methionine into nascent 
chains coded by endogenous mRNA in polysomes 
was monitored in vitro as in [23]. Incorporation 
was determined by trichloroacetic acid precipita- 
tion of protein on filter discs [25]. In this system 
the majority of incorporation represents the com- 
pletion of preexisting nascent polypeptide chains. 
2.6. Determination of 2 ‘,5 ‘-oligo(A) synthetase 
activity 
Preparation of extracts and assays of the activity 
of 2’,5’-oligo(A) synthetase were carried out as in 
[26]. The enzyme was bound to poly(I)* poly(C)- 
agarose, incubated in vitro with [3H]ATP for 20 h 
at 30°C and the products chromatographed on 
DEAE-cellulose. 2’,5’-oligo(A) compounds were 
eluted with 0.35 M KC1 [26]. The activity is ex- 
pressed as nmol ATP converted into 2’,5’-oligo(A) 
per mg protein in the original cytoplasmic extracts. 
2.7. Incorporation of thymidine into DNA 
Thymidine incorporation was determined as in 
[2-51. 
2.8. Determination of protein and RNA in cells 
Protein and total cellular RNA were assayed as 
in [27]. 
Volume 171, number 1 FEBSLETTERS June 1984 
3. RESULTS AND DISCUSSION 
The effects of various times of interferon treat- 
ment on the rate of protein synthesis in Daudi cells 
are listed in table 1. As growth inhibition develops, 
from 24 h onwards, the rate of protein synthesis 
falls relative to that in exponentially growing con- 
trol cells such that a 20-30070 inhibition is observed 
after 24 h, increasing to 60-70% by 48 h and greater 
than 70% thereafter. These rates were determined 
using a rigorous procedure involving labelling with 
saturating concentrations of [‘HI phenylalanine, a 
method which has been substantiated in a number 
of mammalian systems [22]. Table 1 also indicates 
that there is a fall in the RNA content of the cells 
(largely a reflection of the number of ribosomes 
per cell) during the response to interferon treat- 
ment. However, the decline in protein synthesis is 
greater than the decrease in ribosome number. 
As in many interferon-treated cell systems, the 
enzyme 2’,5’-oligo(A) synthetase is induced in 
Daudi cells within 8-12 h [6,28]. Fig.1 illustrates 
the time course of induction and shows that no fur- 
ther increase in enzyme activity is observed after 
24 h. The level of the enzyme thus does not cor- 
Table 1 
Rates of protein synthesis in Daudi cells during inhibition 
of cell proliferation by interferons 
Time of inter- Rate of protein RNA content &g 
feron treatment synthesis bg/106 RNA/ 1 O6 cells) 
(days) cells per h) (&SE) (*SE) (n = 3-5) 
0 (control 
cells) 3.08 zl: 0.08 (26) 11.70 f 1.00 
1 2.34 f 0.08 (5) 9.96 f 0.08 
2 1.12 f 0.13 (10) 8.78 + 0.94 
3 0.83 f 0.05 (12) 8.09 + 0.12 
4 0.74 f 0.10 (12) 521 f 0.48 
Exponentially growing Daudi cells were treated with 
human cu-interferons (5 reference units/ml) and main- 
tained in culture for the times indicated. Rates of protein 
synthesis were calculated from time courses of incor- 
poration of [3H]phenylalanine (2.5&i/ml, 2.5 mM) 
into protein. Specific radioactivities of phenylalanine in 
the extracellular and intracellular amino acid pools and 
in protein were measured as described in section 2. 
Results are expressed as means +SE with numbers of 
determinations given in parentheses 
I I I 
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Fig. 1. Induction of 2’,5’-oligo(A) synthetase by inter- 
ferons in Daudi cells. Exponentially growing cells were 
treated with human cy-interferons (5 reference units/ml) 
and incubated for the times shown (0). Another batch 
of the same population of cells was maintained in culture 
in the absence of interferons (0). Cell extracts were 
prepared by detergent lysis of washed cells and 5,41 of 
each post-mitochondrial supernatant was incubated with 
50~1 poly(I).poly(C)-agarose for 20min at 0°C fol- 
lowed by incubation with 1 mM [3H]ATP and chromato- 
graphy of the products as described in section 2. The 
conversion of ATP to 2’,5’-oligo(A) products is ex- 
pressed as nmol adenylate residues polymerized per mg 
total protein in the cell extracts. 
relate with the increasing inhibition of protein syn- 
thesis observed beyond 24 h. Measurements of 
2’,5’-oligo(A) products in Daudi cells have failed 
to reveal any synthesis of these oligonucleotides 
following interferon treatment [6]. The lack of in- 
volvement of the 2’,5’-(A) system in the effects on 
protein synthesis in Daudi cells is further suggested 
by the data in fig.2. If there had been activation of 
a 2’,5’-(A)-dependent ribonuclease, which degrades 
mRNAs 1291, one would expect to see a more rapid 
decline in protein synthesis following inhibition of 
transcription in the cells [30]. However, when all 
new mRNA synthesis was blocked by the addition 
of 60~M DRB to cultures of control and inter- 
feron-treated Daudi cells, protein synthesis de- 
clined at similar rates in both cases, with a half-life 
of approx. 7-9 h. This suggests that the stability of 
the bulk of the mRNA population is the same in 
control cells and in cells subjected to 48 h of inter- 
feron treatment. 
113 
Volume 171, number 1 FEBS LETTERS June 1984 
0 5 IO I5 
Time (h) 
Fig.2. Rate of decline of protein synthesis in control and 
interferon-treated Daudi cells in the absence of new 
mRNA synthesis. Cells incubated with (0) or without 
(0) interferons (5 reference units/ml) for 48 h were 
treated with 6OpM DRB. Protein synthesis was then 
monitored at the times indicated by the ~cor~ration of 
[3H]leucine (lOpCi/ml, 0.38 mM, 30min at 37°C). 
Duplicate 0.3”ml aliquots of cell suspensions were 
diluted into 5 ml phosphate-buffered saline, the cells 
were washed by centrifugation and the protein in the 
pellets was precipitated with 5% (w/v) trichloroacetic 
acid for determination of acid-insoluble radioactivity. 
The means of 2 separate experiments are shown. The 
results are expressed as % of the incorporation obtained 
before addition of DRB. 
The inhibition of protein synthesis in interferon- 
treated Daudi cells is associated with a decrease in 
the proportion of ribosomes in polysomes, as 
measured both by direct quantitation of polysome 
size distribution on sucrose density gradients 
(fig.3A-D) and by the synthesis of nascent poly- 
peptide chains by Daudi cell extracts in vitro 
(fig.3E). These results suggest inhibition of trans- 
lation at the level of polypeptide chain initiation. 
This has been confirmed in our laboratory by 
analysis of the ability of cell extracts to form initia- 
tion complexes (not shown). Overall our results 
suggest an interferon-induced impairment in the 
activity of one or more components involved in the 
30 
Time (min) 
60 
Fig.3. Disaggregation of polysomes and inhibition of in 
vitro protein synthesis by inteferon treatment. Exponen- 
tially growing Daudi cells were untreated (A) or treated 
with interferons (5 units/ml) for f day (B), 2 days (C) 
and 4 days (D). Cell extracts were prepared as described 
in section 2. Distributions of ribosomes in polysomes 
were determined by centrifugation through 20-50% SUC- 
rose gradients [24] followed by continuous measurement 
of Azae in a recording spectrophotometer. (E) Correspon- 
ding levels of protein synthesis achieved on incubation 
of equal A2s0 amounts of cell extracts with [35S]methio- 
nine (60&i/ml) in vitro under conditions of protein 
synthesis: (0) control, (0) l-day treated, (A) 2-day 
treated, (0) 4-day treated. Radioactivity in protein in 
2O-pl samples is shown. 
initiation process, rather than a decreased stability 
of mRNA, in Daudi cells. 
Our results are relevant o our previous observa- 
tions concerning DNA replication during growth 
inhibition of Daudi cells by interferons f3-51. As 
114 
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Fig.4. Relationship between the rate of protein synthesis 
and incorporation of [3H] thymidine into DNA in Daudi 
cells. Exponentially growing cells were incubated with 
the indicated concentrations of (A) cycloheximide or (B) 
emetine for 30 min and then labelled with [3H]thymidine 
(2pCi/ml) or [ 14C]leucine (ZrCi/ml) for 60 min. Incor- 
poration of radioactivity into DNA (0) or protein (0) 
was determined by trichloroacetic acid precipitation of 
cell suspensions and inhibition is expressed relative to 
the incorporation obtained in the absence of the 
inhibitors. 
fig.4 illustrates, the rate of DNA synthesis is 
closely linked with that of protein synthesis as 
judged by the sensitivities of the two processes to 
the translational inhibitors cycloheximide and 
emetine. The basis for this relationship has not 
been established but it may reflect a continuous 
requirement for synthesis of histones and other 
chromatin-associated proteins during DNA repli- 
cation [8-lo]. In view of the present observations 
concerning protein synthesis during interferon- 
induced growth inhibition, it may be that one or 
more proteins essential for DNA replication are 
synthesised at an insufficient rate to support the 
normal replication of the cellular genome, thus 
leading to defects in the initiation, processing or 
stability of newly replicated DNA. 
It is presently unclear whether the synthesis of 
all cellular proteins is inhibited to an equal extent 
following interferon treatment. In view of the ap- 
parent inhibition of polypeptide chain initiation, it 
is possible that the translation of those mRNAs 
with the lowest affinities for limiting amounts of 
pre-initiation complexes would be preferentially 
inhibited. Conversely, those messages with high 
efficiencies of initiation may continue to be trans- 
lated at near-normal rates [3 11. These considera- 
tions may explain the apparently greater effect of 
interferon treatment on protein synthesis and on 
the stabilty of newly replicated DNA than on the 
rate of DNA polymerisation per se. [5]. Differen- 
tial inhibition of synthesis of different proteins 
could also provide an explanation for the effects of 
interferon treatment on cell differentiation and on 
the expression of specific genes in a variety of cell 
systems [32,33]. 
In conclusion, we have shown that protein syn- 
thesis is strongly inhibited at a rather late stage in 
the response of Daudi cells to human interferon 
treatment and have presented evidence suggesting 
that changes in mRNA stability [and by implica- 
tion the 2’,5’-(A) system] do not constitute a major 
mechanism by which this is achieved. The inhibi- 
tion of polypeptide chain initiation may reflect 
changes in the activity of initiation factor eIF-2, 
which can be phosphorylated by an interferon- 
induced protein kinase [13,14], but this effect 
appears to require 24-48 h of interferon treatment 
before it is manifested. This late response may ex- 
plain the previous failure of others to demonstrate 
substantial inhibition of protein synthesis in un- 
infected, interferon-treated cells in culture. 
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